While human CRISPR trials have been announced, Sangamo's zinc-finger nuclease (ZFN) technology has got there first, but not without some controversy. Hunter syndrome patients lack a critical enzyme called iduronate-2-sulfatase (IDS) which...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)